BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Germann UA, Alam JJ. P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease. Int J Mol Sci 2020;21:E5485. [PMID: 32751991 DOI: 10.3390/ijms21155485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 O’brien JT, Chouliaras L, Sultana J, Taylor J, Ballard C, Aarsland D, Blanc F, Boeve B, Brooks DJ, Chaudhuri KR, Cummings J, Feldman HH, Flicker L, Galvin JE, Grosset DG, Ikeda M, Kohlhaas S, Lawlor B, Lemstra AW, Leroi I, Londos E, Leverenz JB, Lewis S, Mckeith I, Mills R, Oakley R, Richardson J, Sabbagh M, Skidmore J, Svennigsson P, Tiraboschi P, Weintraub D, Walker Z, Watson R, Weil RS, Williams-gray CH, Yarnall A, on behalf of the RENEWAL Study Group. RENEWAL: REpurposing study to find NEW compounds with Activity for Lewy body dementia—an international Delphi consensus. Alz Res Therapy 2022;14:169. [DOI: 10.1186/s13195-022-01103-7] [Reference Citation Analysis]
2 Cai Y, Xiao R, Zhang Y, Xu D, Wang N, Han M, Zhang Y, Zhang L, Zhou W. DHPA Protects SH-SY5Y Cells from Oxidative Stress-Induced Apoptosis via Mitochondria Apoptosis and the Keap1/Nrf2/HO-1 Signaling Pathway. Antioxidants 2022;11:1794. [DOI: 10.3390/antiox11091794] [Reference Citation Analysis]
3 Hazegh K, Fang F, Kelly K, Sinchar D, Wang L, Zuchelkowski BE, Ufelle AC, Esparza O, Davizon-Castillo P, Page GP, Kanias T. Erythrocyte mitogen-activated protein kinases mediate hemolytic events under osmotic and oxidative stress and in hemolytic diseases. Cell Signal 2022;99:110450. [PMID: 36029940 DOI: 10.1016/j.cellsig.2022.110450] [Reference Citation Analysis]
4 Pandey AK, Zerin F, Menon SN, Tithi TI, Nguyen KP, Vo T, Daniel ML, Hafez S, Alam MA, Hasan R. Neflamapimod induces vasodilation in resistance mesenteric arteries by inhibiting p38 MAPKα and downstream Hsp27 phosphorylation. Sci Rep 2022;12:4905. [PMID: 35318382 DOI: 10.1038/s41598-022-08877-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen H, Chen F, Zhang M, Chen Y, Cui L, Liang C. A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer's Disease. J Alzheimers Dis 2021;84:535-55. [PMID: 34569952 DOI: 10.3233/JAD-210602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alam JJ, Nixon RA. Disease-modifying pharmacological approaches to correcting basal forebrain cholinergic neuronal (BFCN) dysfunction and degeneration. Neuropsychopharmacology 2021. [PMID: 34389810 DOI: 10.1038/s41386-021-01135-x] [Reference Citation Analysis]
7 Aikio M, Wobst HJ, Odeh HM, Lee BL, Class B, Ollerhead TA, Mack KL, Ford AF, Barbieri EM, Cupo RR, Drake LE, Castello N, Baral A, Dunlop J, Gitler AD, Javaherian A, Finkbeiner S, Brown DG, Moss SJ, Brandon NJ, Shorter J. Opposing roles of p38α-mediated phosphorylation and arginine methylation in driving TDP-43 proteinopathy.. [DOI: 10.1101/2021.08.04.455154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Koss DJ, Campesan S, Giorgini F, Outeiro TF. Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases. Mov Disord 2021;36:1744-58. [PMID: 33939203 DOI: 10.1002/mds.28605] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Burton JC, Antoniades W, Okalova J, Roos MM, Grimsey NJ. Atypical p38 Signaling, Activation, and Implications for Disease. Int J Mol Sci 2021;22:4183. [PMID: 33920735 DOI: 10.3390/ijms22084183] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
10 Sanz-Ezquerro JJ, Cuenda A. p38 Signalling Pathway. Int J Mol Sci 2021;22:1003. [PMID: 33498296 DOI: 10.3390/ijms22031003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]